Mubadala Investment Co Pjsc

10% Owner | Former 10% Holder | Director +1 more

3 companies

Good

Trades Analyzed

12M Win Rate

96.4%

Avg 3M Return

-11.4%

Avg 12M Return

+46.1%

Mubadala Investment Co Pjsc is a Director at AMD with holdings across 3 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.

Estimated insider holdings value: $40344.7M based on current market prices.

Holdings by Company

AMDFeb 5, 2019

Current Shares75.00M

Value$40.30B

Net Activity-96,906,166

Bought: 0Sold: 96.91M

RXRXMar 2, 2023

Current Shares12.99M

Value$41.94M

Net Activity+4.47M

Bought: 4.47MSold: 0

GAIAMay 1, 2019

Current Shares0

Value-

Net Activity+15.3K

Bought: 15.3KSold: 0

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 2, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	66,822	$7.82	$522,354.26	+0.5%	+9.5%	+59.9%
Mar 1, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	48,867	$7.94	$388,082.17	+0.4%	+10.9%	+69.3%
Feb 28, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	815	$7.97	$6,495.55	-	+8.2%	+58.8%
Feb 27, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	52,500	$7.69	$403,725.00	+0.4%	+14.2%	+101.0%
Feb 24, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	109,118	$7.64	$833,552.40	+0.9%	+13.8%	+75.7%
Feb 23, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	51,864	$7.79	$403,792.36	+0.4%	+14.1%	+70.3%
Feb 22, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	50,941	$7.83	$399,015.76	+0.4%	+16.5%	+88.9%
Feb 21, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	94,418	$7.74	$731,125.78	+0.8%	+5.3%	+60.4%
Feb 17, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	63,382	$7.71	$488,985.79	+0.5%	-31.5%	+64.6%
Feb 16, 2023	RXRX Recursion Pharmaceuticals, Inc.	10% Owner	Buy	42,682	$7.90	$337,042.68	+0.3%	-31.2%	+68.2%